Please login to the form below

Not currently logged in
Email:
Password:

RPSGB promotes excellence In pharmacy research

The Royal Pharmaceutical Society of Great Britain (RPSGB) has awarded the University of Nottingham's School of Pharmacy with a platform to promote the next generation of research talent.

The Royal Pharmaceutical Society of Great Britain (RPSGB) has awarded the University of Nottingham's School of Pharmacy with a platform to promote the next generation of research talent.

The School of Pharmacy will host an Academic Excellence Award in 2008, which is a prestigious programme of PhD studentships offered by the RPSGB.

Nottingham was one of only two UK institutions selected from among 23 applicants, after a judging process involving a panel of distinguished pharmacy academics.

The RPSGB Academic Excellence Awards hope to increase the number of pharmacists who enter and stay in academia as a career by providing funding to enable exceptional pharmacists and pharmacy graduates to undertake PhD training. The scheme promotes the important role played by members of the academic workforce in developing and leading the profession of pharmacy.

The University will host an award for research with the title 'Selective inhibitors for nuclear receptors: an alternative to anti-hormone therapies', supervised by Professor David Heery. This work investigates the mechanisms by which genes are switched on or off in healthy or diseased human cells.

The award is only the latest accolade for the highly-rated School of Pharmacy. In April this year the School won a Queen's Award for Enterprise in the category of Innovation. Cardiff University was the other institution to be successful in the Academic Excellence Awards for 2008.

20th August 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ experience, Innovative Trials deploys “boots-on-the-ground”...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...